UNICYCIVE THERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | $-884.0K | $15.0K |
| Mar 2020 | — | $-1.1M | — |
| Jun 2020 | — | $-1.3M | $1.0K |
| Sep 2020 | — | $-1.9M | $63.0K |
| Dec 2020 | — | $-2.7M | — |
| Mar 2021 | — | $-3.4M | $147.0K |
| Jun 2021 | — | $-4.2M | $1.0K |
| Sep 2021 | — | $19.0M | $18.0M |
| Dec 2021 | — | $16.5M | $16.6M |
| Mar 2022 | — | $13.2M | $13.6M |
| Jun 2022 | — | $9.9M | $10.6M |
| Sep 2022 | — | $4.6M | $7.0M |
| Dec 2022 | — | $-466.0K | $455.0K |
| Mar 2023 | — | $-15.1M | $24.3M |
| Jun 2023 | — | $-19.4M | $18.8M |
| Sep 2023 | — | $3.4M | $14.3M |
| Dec 2023 | — | $-3.8M | $9.7M |
| Mar 2024 | — | $-24.5M | $48.9M |
| Jun 2024 | — | $-14.8M | $41.8M |
| Sep 2024 | — | $-27.9M | $32.3M |
| Dec 2024 | — | $7.4M | $26.1M |
| Mar 2025 | — | $11.3M | $19.8M |
| Jun 2025 | — | $16.4M | $22.3M |
| Sep 2025 | — | $37.5M | $42.7M |
| Dec 2025 | — | $30.2M | $29.2M |
| Mar 2026 | — | $37.7M | $37.4M |
| Jun 2026 | — | $53.3M | $44.2M |